ARTICLE | Clinical News
Cipro ciprofloxacin regulatory update
March 22, 2010 7:00 AM UTC
FDA granted Orphan Drug designation for Bayer's ciprofloxacin dry powder inhaler (DPI) for the management of pulmonary infection due to Psuedomonas aeruginosa in cystic fibrosis (CF) patients. The inh...